The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Danilova N.V.

Lomonosov Moscow State University

Oleynikova N.A.

Lomonosov Moscow State University

E-cadherin: structure and functions, role in gastric cancer carcinogenesis

Authors:

Danilova N.V., Oleynikova N.A.

More about the authors

Read: 3719 times


To cite this article:

Danilova NV, Oleynikova NA. E-cadherin: structure and functions, role in gastric cancer carcinogenesis. Russian Journal of Archive of Pathology. 2023;85(4):70‑77. (In Russ.)
https://doi.org/10.17116/patol20238504170

Recommended articles:
Claudin-18.2 and gastric cancer: from physiology to carcinogenesis. Russian Journal of Archive of Pathology. 2024;(6):92-99
The phenomenon of tumor budding in gastric cancer. Russian Journal of Archive of Pathology. 2025;(2):79-87
Pancreaticoduodenectomy combined with multivisceral rese­ctions. Piro­gov Russian Journal of Surgery. 2024;(11):77-83
Effi­cacy of alpha-glutamyl-tryptophan in the treatment of chro­nic atro­phic gastritis: case series. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):121-128
Gastric cancer: inci­dence, risk factors, screening. Russian Journal of Preventive Medi­cine. 2024;(12):135-139
Redu­ction of cyto­skeleton gene expression in tumor cells during lentivirus transduction. Mole­cular Gene­tics, Microbiology and Viro­logy. 2025;(1):30-37

References:

  1. Mendonsa AM, Na TY, Gumbiner BM. E-cadherin in contact inhibition and cancer. Oncogene. 2018;37(35):4769-4780. https://doi.org/10.1038/s41388-018-0304-2
  2. van Roy F, Berx G. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci. 2008;65(23):3756-3788. https://doi.org/10.1007/s00018-008-8281-1
  3. Liu X, Chu KM. E-cadherin and gastric cancer: cause, consequence, and ampplications. Biomed Res Int. 2014;2014:637308. https://doi.org/10.1155/2014/637308
  4. Yap AS, Niessen CM, Gumbiner BM. The juxtamembrane region of the cadherin cytoplasmic tail supports lateral clustering, adhesive strengthening, and interaction with p120ctn. J Cell Biol. 1998;141(3):779-789.  https://doi.org/10.1083/jcb.141.3.779
  5. Mareel M, Oliveira MJ, Madani I. Cancer invasion and metastasis: interacting ecosystems. Virchows Arch. 2009;454(6):599-622.  https://doi.org/10.1007/s00428-009-0784-0
  6. Takeichi M, Matsunami H, Inoue T, Kimura Y, Suzuki S, Tanaka T. Roles of cadherins in patterning of the developing brain. Dev Neurosci. 1997;19(1):86-87.  https://doi.org/10.1159/000111189
  7. Fujimori T, Miyatani S, Takeichi M. Ectopic expression of N-cadherin perturbs histogenesis in Xenopus embryos. Development. 1990;110(1):97-104.  https://doi.org/10.1242/dev.110.1.97
  8. Kan NG, Stemmler MP, Junghans D, Kanzler B, de Vries WN, Dominis M, Kemler R. Gene replacement reveals a specific role for E-cadherin in the formation of a functional trophectoderm. Development. 2007;134(1):31-41.  https://doi.org/10.1242/dev.02722
  9. Higgins JM, Mandlebrot DA, Shaw SK, Russell GJ, Murphy EA, Chen YT, Nelson WJ, Parker CM, Brenner MB. Direct and regulated interaction of integrin alphaEbeta7 with E-cadherin. J Cell Biol. 1998;140(1):197-210.  https://doi.org/10.1083/jcb.140.1.197
  10. Schön MP, Arya A, Murphy EA, Adams CM, Strauch UG, Agace WW, Marsal J, Donohue JP, Her H, Beier DR, et al. Mucosal T lymphocyte numbers are selectively reduced in integrin alpha E (CD103)-deficient mice. J Immunol. 1999;162(11):6641-6649.
  11. Le Floc’h A, Jalil A, Vergnon I, Le Maux Chansac B, Lazar V, Bismuth G, Chouaib S, Mami-Chouaib F. Alpha E beta 7 integrin interaction with E-cadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosis. J Exp Med. 2007;204(3):559-570.  https://doi.org/10.1084/jem.20061524
  12. Anderton JM, Rajam G, Romero-Steiner S, Summer S, Kowalczyk AP, Carlone GM, Sampson JS, Ades EW. E-cadherin is a receptor for the common protein pneumococcal surface adhesin A (PsaA) of Streptococcus pneumoniae. Microb Pathog. 2007; 42(5-6):225-236.  https://doi.org/10.1016/j.micpath.2007.02.003
  13. Phan QT, Myers CL, Fu Y, Sheppard DC, Yeaman MR, Welch WH, Ibrahim AS, Edwards JE Jr, Filler SG. Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells. PLoS Biol. 2007;5(3):e64.  https://doi.org/10.1371/journal.pbio.0050064
  14. Sommariva M, Gagliano N. E-Cadherin in pancreatic ductal adenocarcinoma: a multifaceted actor during EMT. Cells. 2020; 9(4):1040. https://doi.org/10.3390/cells9041040
  15. Na TY, Schecterson L, Mendonsa AM, Gumbiner BM. The functional activity of E-cadherin controls tumor cell metastasis at multiple steps. Proc Natl Acad Sci USA. 2020;117(11):5931-5937. https://doi.org/10.1073/pnas.1918167117
  16. Biswas KH. Molecular mobility-mediated regulation of E-cadherin adhesion. Trends Biochem Sci. 2020;45(2):163-173.  https://doi.org/10.1016/j.tibs.2019.10.012
  17. Rodriguez FJ, Lewis-Tuffin LJ, Anastasiadis PZ. E-cadherin’s dark side: possible role in tumor progression. Biochim Biophys Acta. 2012;1826(1):23-31.  https://doi.org/10.1016/j.bbcan.2012.03.002
  18. Bure IV, Nemtsova MV, Zaletaev DV. Roles of E-cadherin and noncoding RNAs in the epithelial-mesenchymal transition and progression in gastric cancer. Int J Mol Sci. 2019;20(12):2870. https://doi.org/10.3390/ijms20122870
  19. Togasaki K, Sugimoto S, Ohta Y, Nanki K, Matano M, Takahashi S, Fujii M, Kanai T, Sato T. Wnt signaling shapes the histologic variation in diffuse gastric cancer. Gastroenterology. 2021; 160(3):823-830.  https://doi.org/10.1053/j.gastro.2020.10.047
  20. Chan AO. E-cadherin in gastric cancer. World J Gastroenterol. 2006;12(2):199-203.  https://doi.org/10.3748/wjg.v12.i2.199
  21. van Zijl F, Krupitza G, Mikulits W. Initial steps of metastasis: cell invasion and endothelial transmigration. Mutat Res. 2011;728(1-2): 23-34.  https://doi.org/10.1016/j.mrrev.2011.05.002
  22. Kim J, Yu W, Kovalski K, Ossowski L. Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell. 1998;94(3):353-362.  https://doi.org/10.1016/s0092-8674(00)81478-6
  23. Alpaugh ML, Tomlinson JS, Kasraeian S, Barsky SH. Cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma. Oncogene. 2002;21(22):3631-3643. https://doi.org/10.1038/sj.onc.1205389
  24. Tomlinson JS, Alpaugh ML, Barsky SH. An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma. Cancer Res. 2001;61(13):5231-5241.
  25. Ye Y, Tellez JD, Durazo M, Belcher M, Yearsley K, Barsky SH. E-cadherin accumulation within the lymphovascular embolus of inflammatory breast cancer is due to altered trafficking. Anticancer Res. 2010;30(10):3903-3910.
  26. Silvera D, Arju R, Darvishian F, Levine PH, Zolfaghari L, Goldberg J, Hochman T, Formenti SC, Schneider RJ. Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer. Nat Cell Biol. 2009;11(7):903-908.  https://doi.org/10.1038/ncb1900
  27. Kang HG, Jenabi JM, Zhang J, Keshelava N, Shimada H, May WA, Ng T, Reynolds CP, Triche TJ, Sorensen PH. E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase. Cancer Res. 2007;67(7):3094-3105. https://doi.org/10.1158/0008-5472.can-06-3259
  28. Berx G, van Roy F. Involvement of members of the cadherin superfamily in cancer. Cold Spring Harb Perspect Biol. 2009;1(6):a003129. https://doi.org/10.1101/cshperspect.a003129
  29. Becker KF, Atkinson MJ, Reich U, Huang HH, Nekarda H, Siewert JR, Höfler H. Exon skipping in the E-cadherin gene transcript in metastatic human gastric carcinomas. Hum Mol Genet. 1993;2(6):803-804.  https://doi.org/10.1093/hmg/2.6.803
  30. Carvalho J, van Grieken NC, Pereira PM, Sousa S, Tijssen M, Buffart TE, Diosdado B, Grabsch H, Santos MA, Meijer G, et al. Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer. J Pathol. 2012;228(1):31-44.  https://doi.org/10.1002/path.4032
  31. Paredes J, Figueiredo J, Albergaria A, Oliveira P, Carvalho J, Ribeiro AS, Caldeira J, Costa AM, Simoes-Correia J, Oliveira MJ, et al. Epithelial E- and P-cadherins: role and clinical significance in cancer. Biochim Biophys Acta. 2012;1826(2):297-311.  https://doi.org/10.1016/j.bbcan.2012.05.002
  32. Katona BW, Rustgi AK. Gastric cancer genomics: advances and future directions. Cell Mol Gastroenterol Hepatol. 2017;3(2):211-217.  https://doi.org/10.1016/j.jcmgh.2017.01.003
  33. Oki Y, Issa JP. Epigenetic mechanisms in AML — a target for therapy. Cancer Treat Res. 2010;145:19-40.  https://doi.org/10.1007/978-0-387-69259-3_2
  34. Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014; 513(7517):202-209.  https://doi.org/10.1038/nature13480
  35. Reynolds AB, Roczniak-Ferguson A. Emerging roles for p120-catenin in cell adhesion and cancer. Oncogene. 2004;23(48):7947-7956. https://doi.org/10.1038/sj.onc.1208161
  36. Chen GT, Waterman ML. Cancer: leaping the E-cadherin hurdle. EMBO J. 2015;34(18):2307-2309. https://doi.org/10.15252/embj.201592757
  37. Suriano G, Mulholland D, de Wever O, Ferreira P, Mateus AR, Bruyneel E, Nelson CC, Mareel MM, Yokota J, Huntsman D, et al. The intracellular E-cadherin germline mutation V832 M lacks the ability to mediate cell-cell adhesion and to suppress invasion. Oncogene. 2003;22(36):5716-5719. https://doi.org/10.1038/sj.onc.1206672
  38. Gottardi CJ, Wong E, Gumbiner BM. E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. J Cell Biol. 2001;153(5):1049-1060. https://doi.org/10.1083/jcb.153.5.1049
  39. Torres VA, Tapia JC, Rodriguez DA, Lladser A, Arredondo C, Leyton L, Quest AF. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription. Mol Cell Biol. 2007;27(21):7703-7717. https://doi.org/10.1128/mcb.01991-06
  40. Lawson CD, Ridley AJ. Rho GTPase signaling complexes in cell migration and invasion. J Cell Biol. 2018;217(2):447-457.  https://doi.org/10.1083/jcb.201612069
  41. Svensmark JH, Brakebusch C. Rho GTPases in cancer: friend or foe? Oncogene. 2019;38(50):7447-7456. https://doi.org/10.1038/s41388-019-0963-7
  42. Hotulainen P, Lappalainen P. Stress fibers are generated by two distinct actin assembly mechanisms in motile cells. J Cell Biol. 2006;173(3):383-394.  https://doi.org/10.1083/jcb.200511093
  43. Pece S, Gutkind JS. Signaling from E-cadherins to the MAPK pathway by the recruitment and activation of epidermal growth factor receptors upon cell-cell contact formation. J Biol Chem. 2000;275(52):41227-41233. https://doi.org/10.1074/jbc.M006578200
  44. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2(6):442-454.  https://doi.org/10.1038/nrc822
  45. Qian X, Karpova T, Sheppard AM, McNally J, Lowy DR. E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases. EMBO J. 2004;23(8):1739-1748. https://doi.org/10.1038/sj.emboj.7600136
  46. Mateus AR, Seruca R, Machado JC, Keller G, Oliveira MJ, Suriano G, Luber B. EGFR regulates RhoA-GTP dependent cell motility in E-cadherin mutant cells. Hum Mol Genet. 2007;16(13):1639-1647. https://doi.org/10.1093/hmg/ddm113
  47. Mateus AR, Simoes-Correia J, Figueiredo J, Heindl S, Alves CC, Suriano G, Luber B, Seruca R. E-cadherin mutations and cell motility: a genotype-phenotype correlation. Exp Cell Res. 2009;315(8): 1393-1402. https://doi.org/10.1016/j.yexcr.2009.02.020
  48. Mook OR, Frederiks WM, Van Noorden CJ. The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta. 2004;1705(2):69-89.  https://doi.org/10.1016/j.bbcan.2004.09.006
  49. Munshi HG, Ghosh S, Mukhopadhyay S, Wu YI, Sen R, Green KJ, Stack MS. Proteinase suppression by E-cadherin-mediated cell-cell attachment in premalignant oral keratinocytes. J Biol Chem. 2002;277(41):38159-38167. https://doi.org/10.1074/jbc.M202384200
  50. Ryniers F, Stove C, Goethals M, Brackenier L, Noë V, Bracke M, Vandekerckhove J, Mareel M, Bruyneel E. Plasmin produces an E-cadherin fragment that stimulates cancer cell invasion. Biol Chem. 2002;383(1):159-165.  https://doi.org/10.1515/bc.2002.016
  51. Ferreira AC, Suriano G, Mendes N, Gomes B, Wen X, Carneiro F, Seruca R, Machado JC. E-cadherin impairment increases cell survival through Notch-dependent upregulation of Bcl-2. Hum Mol Genet. 2012;21(2):334-343.  https://doi.org/10.1093/hmg/ddr469
  52. Balakrishnan M, George R, Sharma A, Graham DY. Changing trends in stomach cancer throughout the world. Curr Gastroenterol Rep. 2017;19(8):36.  https://doi.org/10.1007/s11894-017-0575-8
  53. Rugge M, Genta RM, Di Mario F, El-Omar EM, El-Serag HB, Fassan M, Hunt RH, Kuipers EJ, Malfertheiner P, Sugano K, et al. Gastric cancer as preventable disease. Clin Gastroenterol Hepatol. 2017;15(12):1833-1843. https://doi.org/10.1016/j.cgh.2017.05.023
  54. Chan AO, Lam SK, Wong BC, Wong WM, Yuen MF, Yeung YH, Hui WM, Rashid A, Kwong YL. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut. 2003;52(4):502-506.  https://doi.org/10.1136/gut.52.4.502
  55. Leung WK, Man EP, Yu J, Go MY, To KF, Yamaoka Y, Cheng VY, Ng EK, Sung JJ. Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach. Clin Cancer Res. 2006;12(10):3216-3221. https://doi.org/10.1158/1078-0432.ccr-05-2442
  56. Perri F, Cotugno R, Piepoli A, Merla A, Quitadamo M, Gentile A, Pilotto A, Annese V, Andriulli A. Aberrant DNA methylation in non-neoplastic gastric mucosa of H. pylori infected patients and effect of eradication. Am J Gastroenterol. 2007;102(7):1361-1371. https://doi.org/10.1111/j.1572-0241.2007.01284.x
  57. Chan AO, Peng JZ, Lam SK, Lai KC, Yuen MF, Cheung HK, Kwong YL, Rashid A, Chan CK, Wong BC. Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation. Gut. 2006;55(4):463-468.  https://doi.org/10.1136/gut.2005.077776
  58. Conlin VS, Curtis SB, Zhao Y, Moore ED, Smith VC, Meloche RM, Finlay BB, Buchan AM. Helicobacter pylori infection targets adherens junction regulatory proteins and results in increased rates of migration in human gastric epithelial cells. Infect Immun. 2004;72(9):5181-5192. https://doi.org/10.1128/iai.72.9.5181-5192.2004
  59. Suzuki M, Mimuro H, Suzuki T, Park M, Yamamoto T, Sasakawa C. Interaction of CagA with Crk plays an important role in Helicobacter pylori-induced loss of gastric epithelial cell adhesion. J Exp Med. 2005;202(9):1235-1247. https://doi.org/10.1084/jem.20051027
  60. Ogden SR, Wroblewski LE, Weydig C, Romero-Gallo J, O’Brien DP, Israel DA, Krishna US, Fingleton B, Reynolds AB, Wessler S, et al. p120 and Kaiso regulate Helicobacter pylori-induced expression of matrix metalloproteinase-7. Mol Biol Cell. 2008;19(10): 4110-4121. https://doi.org/10.1091/mbc.e08-03-0283
  61. Sokolova O, Bozko PM, Naumann M. Helicobacter pylori suppresses glycogen synthase kinase 3beta to promote beta-catenin activity. J Biol Chem. 2008;283(43):29367-29374. https://doi.org/10.1074/jbc.M801818200
  62. Bebb JR, Leach L, Zaitoun A, Hand N, Letley DP, Thomas R, Atherton JC. Effects of Helicobacter pylori on the cadherin-catenin complex. J Clin Pathol. 2006;59(12):1261-1266. https://doi.org/10.1136/jcp.2006.036772
  63. Backert S, Tegtmeyer N. Type IV secretion and signal transduction of Helicobacter pylori CagA through interactions with host cell receptors. Toxins (Basel). 2017;9(4):115.  https://doi.org/10.3390/toxins9040115
  64. Khatun S, Appidi T, Rengan AK. The role played by bacterial infections in the onset and metastasis of cancer. Curr Res Microb Sci. 2021;2:100078. https://doi.org/10.1016/j.crmicr.2021.100078
  65. Di Pinto F, Armentano R, Arborea G, Schena N, Donghia R, Valentini AM. Are immunohistochemical markers useful in phenotypic gastric cancer classification? Oncology. 2020;98(8):566-574.  https://doi.org/10.1159/000506077
  66. Machlowska J, Maciejewski R, Sitarz R. The pattern of signatures in gastric cancer prognosis. Int J Mol Sci. 2018;19(6):1658. https://doi.org/10.3390/ijms19061658
  67. Setia N, Agoston AT, Han HS, Mullen JT, Duda DG, Clark JW, Deshpande V, Mino-Kenudson M, Srivastava A, Lennerz JK, et al. A protein and mRNA expression-based classification of gastric cancer. Mod Pathol. 2016;29(7):772-784.  https://doi.org/10.1038/modpathol.2016.55
  68. Gabbert HE, Mueller W, Schneiders A, Meier S, Moll R, Birchmeier W, Hommel G. Prognostic value of E-cadherin expression in 413 gastric carcinomas. Int J Cancer. 1996;69(3):184-189.  https://doi.org/10.1002/(sici)1097-0215(19960621)69:3<184::aid-ijc6>3.0.co;2-w
  69. Wijnhoven BP, Dinjens WN, Pignatelli M. E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg. 2000;87(8):992-1005. https://doi.org/10.1046/j.1365-2168.2000.01513.x

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.